Select Page

The MiGHT study has now closed.

Thank you to the study coordinator Beth Rizzo and to all the practices and patients who participated.

The cost to patients for genetic testing is often $250 or less.

MDHHS offers a hereditary cancer hotline for patients and providers with questions: 1-866-852-1247

For additional information about the MiGHT study, please visit info.mightstudy.org.

 

Below are the publications from the MiGHT study to date.

Effects of Healthcare Provider Recommendation for Genetic Testing

Motivational Interviewing for Genetic Counseling: A Unified Framework for Persuasive and Equipoise Conversations

The Michigan Genetic Hereditary Testing (MiGHT) Study’s Innovative Approaches to Promote Uptake of Clinical Genetic Testing Among Cancer Patients: a Study Protocol for a 3-arm Randomized Controlled Trial

Psychosocial Factors Impacting Barriers and Motivators to Cancer Genetic Testing

Creation and Beta Testing of a “Choose Your Own Adventure” Digital Simulation to Reinforce Motivational Interviewing Skills in Genetic Counseling

Effect of Demographic and Clinician Factors on Patients’ Likelihood of Pursuing Hereditary Cancer Genetic Testing

Impact of Barriers and Benefits on Patient Intention and Confidence to Undergo Hereditary Cancer Genetic Testing

Applying Theories, Models, and Frameworks to Help Genetic Counselors and Students Achieve Clinical and Professional Goals

Crop Image

TRANSLATE »